Omron (OTCMKTS:OMRNY) Updates FY 2026 Earnings Guidance

Omron (OTCMKTS:OMRNY) updated its FY 2026 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of 0.890-0.890 for the period, compared to the consensus estimate of 1.220. The company issued revenue guidance of $5.2 billion-$5.2 billion, compared to the consensus revenue estimate of 0.000.

Wall Street Analyst Weigh In

Separately, Zacks Research upgraded shares of Omron from a “strong sell” rating to a “hold” rating in a research note on Monday, January 19th. One investment analyst has rated the stock with a Hold rating, Based on data from MarketBeat, the company presently has a consensus rating of “Hold”.

Omron Price Performance

OMRNY opened at $37.62 on Friday. The company has a quick ratio of 1.37, a current ratio of 2.11 and a debt-to-equity ratio of 0.13. The company’s 50-day moving average price is $31.27 and its 200 day moving average price is $28.56. Omron has a fifty-two week low of $23.23 and a fifty-two week high of $40.76. The firm has a market cap of $7.40 billion, a price-to-earnings ratio of 47.62, a price-to-earnings-growth ratio of 0.44 and a beta of 1.16.

About Omron

Omron Corporation (OTCMKTS: OMRNY) is a global leader in automation, sensing, and control technologies. The company designs, manufactures, and sells a wide range of products and solutions for industrial, healthcare and social systems applications. Its core business segments include industrial automation—featuring programmable logic controllers, sensors, relays, servo motors and temperature controllers—and healthcare products such as blood pressure monitors, digital thermometers and nebulizers.

Founded in 1933 by Kazuma Tateishi in Kyoto, Japan, Omron began with the development of the first Japanese automatic timer.